These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 12612656

  • 1. Translational approaches to improving cervical screening.
    Baldwin P, Laskey R, Coleman N.
    Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
    [Abstract] [Full Text] [Related]

  • 2. Cervical cancer screening in the early post vaccine era.
    Waxman AG.
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [Abstract] [Full Text] [Related]

  • 3. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A.
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N.
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [Abstract] [Full Text] [Related]

  • 6. [Status of screening tests for cervical cancer and its precancerous lesion].
    Zhao FH, Rong SD, Qiao YL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
    [Abstract] [Full Text] [Related]

  • 7. New technologies in gynecologic cytology.
    Bishop JW, Marshall CJ, Bentz JS.
    J Reprod Med; 2000 Sep; 45(9):701-19. PubMed ID: 11027079
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.
    de Cremoux P, Coste J, Sastre-Garau X, Thioux M, Bouillac C, Labbé S, Cartier I, Ziol M, Dosda A, Le Galès C, Molinié V, Vacher-Lavenu MC, Cochand-Priollet B, Vielh P, Magdelénat H, French Society of Clinical Cytology Study Group.
    Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Abnormal pap smears in adolescents.
    Bacon J, Francoeur D, Goldfarb AF, Breech LL.
    J Pediatr Adolesc Gynecol; 2003 Jun; 16(3):157-66. PubMed ID: 12804941
    [No Abstract] [Full Text] [Related]

  • 16. Cost of screening for cancerous and precancerous lesions of the cervix.
    Méréa E, Le Galès C, Cochand-Priollet B, Cartier I, de Crémoux P, Vacher-Lavenu MC, Vielh P, Coste J.
    Diagn Cytopathol; 2002 Oct; 27(4):251-7. PubMed ID: 12357505
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human papillomavirus and cervical cancer screening. Recent advances improve the clinical picture.
    Berman NR.
    Adv Nurse Pract; 2002 Oct; 10(10):26-35; quiz 35-6. PubMed ID: 12424881
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.